Reports

Ideas That Generate Results

Global Point-of-Care Diagnostics Market Outlook 2018

Global Point-of-Care Diagnostics Market Outlook 2018

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : May, 2014| No. of Pages : 90

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1000.00
CD-ROM Mail Delivery
US$ 1100.00
Hard Copy Mail Delivery
US$ 1100.00
Electronic Access - Multi-User License
US$ 1500.00

List of Figures:

Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 3-2: Global - In Vitro Diagnostic Market by Region (%), 2013
Figure 3-3: Global - In Vitro Diagnostic Market by Region (%), 2018
Figure 3-4: Global - In Vitro Diagnostic Market by Players (%), 2013
Figure 4-1: Global - Point-of-Care Testing Market (Billion US$), 2013-2018
Figure 5-1: Global - Point-of-Care Testing Market by Region (%), 2013
Figure 5-2: United States - POCT Market (Billion US$), 2013-2018
Figure 5-3: Canada - POCT Market (Billion US$), 2013-2018
Figure 5-4: Brazil - POCT Market (Billion US$), 2013-2018
Figure 5-5: Europe - POCT Market (Billion US$), 2013-2018
Figure 5-6: Japan - POCT Market (Billion US$), 2013-2018
Figure 5-7: China - POCT Market (Billion US$), 2013-2018
Figure 7-1: Global - Point-of-Care Testing Market by Players (%), 2013
Figure 7-2: Roche Holdings Ltd - Revenue by Business Segment (%), 2013
Figure 7-3: Roche Holdings Ltd - Diagnostic Division Revenue by Region (%), 2013
Figure 7-4: Roche Holdings Ltd - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-5: Abbott Laboratories - Revenue by Business Segment (%), 2013
Figure 7-6: Abbott Laboratories - Revenue by Region (%), 2013
Figure 7-7: Abbott Laboratories - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-8: Johnson & Johnson - Revenue by Business Segment (%), 2013
Figure 7-9: Johnson & Johnson - Medical Devices and Dx Revenue by Segment (%), 2013
Figure 7-10: Johnson & Johnson - Revenue by Region (%), 2013
Figure 7-11: Johnson & Johnson - Medical Devices and Dx Revenue by Region (%), 2013
Figure 7-12: Alere Inc. - Revenue by Business Segment (%), 2012
Figure 7-13: Alere Inc. - Professional Diagnostic Division Revenue by Segment (%), 2012
Figure 7-14: Medtronic Inc. - Revenue by Business Segment (%), 2013
Figure 7-15: Medtronic Inc. - Revenue by Region (%), 2013
Figure 7-16: Medtronic Inc. - Restorative Therapy Revenue by Segment (%), 2013
Figure 7-17: Bayer HealthCare - Revenue by Business Segment (%), 2013
Figure 7-18: Bayer HealthCare - Revenue by Business Region (%), 2013
Figure 7-19: Bayer HealthCare - Consumer Health Revenue by Segment (%), 2013
Figure 7-20: Siemens HealthCare - Revenue by Region (%), 2013
Figure 7-21: Siemens HealthCare - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-22: Bio-Rad - Revenue by Segment (%), 2013
Figure 7-23: Bio-Rad - Revenue by Region (%), 2013
Figure 7-24: Becton Dickinson - Revenue by Business Segment (%), 2013
Figure 7-25: Becton Dickinson - Revenue by Region (%), 2013
Figure 7-26: Becton Dickinson - Diagnostic Division Revenue by Segment (%), 2013

List of Tables:

Table 7-1: Roche - POCT Product Portfolio
Table 7-2: Roche Holding Ltd - Key Financials (Million CHF), 2011-2013
Table 7-3: Roche Holding Ltd - Strengths and Weaknesses
Table 7-4: Abbott - POCT Product Portfolio
Table 7-5: Abbott Laboratories - Key Financials (Million US$), 2011-2013
Table 7-6: Abbott Laboratories - Strengths and Weaknesses
Table 7-7: Johnson and Johnson - POCT Product Portfolio
Table 7-8: Johnson & Johnson - Key Financials (Million US$), 2011-2013
Table 7-9: Johnson & Johnson - Strengths and Weaknesses
Table 7-10: Alere - POCT Product Portfolio
Table 7-11: Alere Inc. - Key Financials (Million US$), 2010-2012
Table 7-12: Alere Inc. - Strengths and Weaknesses
Table 7-13: Medtronic - POCT Product Portfolio
Table 7-14: Medtronic Inc. - Key Financials (Million US$), 2011-2013
Table 7-15: Medtronic Inc. - Strengths and Weaknesses
Table 7-16: Bayer - POCT Product Portfolio
Table 7-17: Bayer HealthCare - Key Financials (Million €), 2011-2013
Table 7-18: Bayer HealthCare - Strengths and Weaknesses
Table 7-19: Siemens - POCT Product Portfolio
Table 7-20: Siemens AG - Key Financials (Million €), 2011-2013
Table 7-21: Siemens - Strength and Weaknesses
Table 7-22: Beckman-Coulter - POCT Product Portfolio
Table 7-23: Beckman Coulter - Strengths and Weaknesses
Table 7-24: Bio-Rad - POCT Product Portfolio
Table 7-25 BioRad - Key Financials (Million US$) 2011-2013
Table 7-26: Becton Dickinson - POCT Product Portfolio
Table 7-27: Becton Dickinson - Key Financials (Million US$), 2011-2013
Table 7-28: Becton Dickinson - Strengths and Weaknesses

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.